Tech Company Financing Transactions
Orum Therapeutics Funding Round
Orum Therapeutics, operating out of Cambridge, secured $100 million from KB Investment, Aon and Company K Partners.
Transaction Overview
Company Name
Announced On
12/18/2025
Transaction Type
Amount
$100,000,000
Round
Undisclosed
Investors
Proceeds Purpose
This investment supports the advancement of ORM-1153 and additional programs in Orum's pipeline and continued refinement of the Company's DAC platforms, including development of additional novel payload classes beyond GSPT1. It also supports the expansion of Orum's scientific and operational infrastructure as the Company advances additional targeted DAC programs based on principles of selectivity, potency, and rational payload design. These efforts are foundational to Orum's strategy to generate differentiated therapeutic DAC programs for oncology and other serious diseases.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
20 Acorn Park Dr.
Cambridge, MA 02140
USA
Cambridge, MA 02140
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Orum Therapeutics is a private biotech company developing a new class of therapeutic antibodies to bring new medicines to patients with unmet medical needs. Orum leverages its unique cell penetrating antibody platform to inhibit drug targets undruggable by small molecule or current antibody therapeutics.
Management Team
Browse more venture capital transactions:
Prev: 12/18/2025: Atavistik Bio venture capital transaction
Next: 12/18/2025: Bahn Express venture capital transaction
Share this article
About Database of VC Transactions
We do our best to document every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs








